What drugs does BIOCODEX SA make?

BIOCODEX SA has 1 FDA-approved drugs including DIACOMIT.

What therapeutic areas does BIOCODEX SA focus on?

BIOCODEX SA focuses primarily on Gastroenterology and Neurology.

← Back

Data updated: Mar 10, 2026

BIOCODEX SA

GastroenterologyNeurology

Pharma

BIOCODEX SA is a pharmaceutical company focused on Gastroenterology, Neurology. Key products include DIACOMIT.

2018

Since

Drugs

Trials

Approved (2yr)

Key Drugs

DIACOMIT

stiripentol

· 2018

Recent Activity

No recent activity

SEC Filings ProEarly access

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Gastroenterology 80%

0 drugs Phase 3: 1

Neurology 20%

0 drugs Phase 1: 1

Pipeline Strength ProEarly access

Competitors ProEarly access

Bristol-Myers Squibb big-pharma

Gastroenterology, Neurology

Takeda big-pharma

Gastroenterology, Neurology

VALIDUS PHARMS specialty

Gastroenterology, Neurology

Amgen biotech

Gastroenterology, Neurology

EMD SERONO INC biotech

Neurology, Gastroenterology

BIOCODEX SA

Key Drugs

Recent Activity

Therapeutic Focus

Pipeline Strength ProEarly access

Competitors ProEarly access

All Drugs (1)

Active (1)

Discontinued (0)

Company Info